148 related articles for article (PubMed ID: 12196647)
1. Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region.
de Jong BA; Huizinga TW; Zanelli E; Giphart MJ; Bollen EL; Uitdehaag BM; Polman CH; Westendorp RG
Neurology; 2002 Aug; 59(4):549-55. PubMed ID: 12196647
[TBL] [Abstract][Full Text] [Related]
2. Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosus.
van der Linden MW; van der Slik AR; Zanelli E; Giphart MJ; Pieterman E; Schreuder GM; Westendorp RG; Huizinga TW
Genes Immun; 2001 Nov; 2(7):373-80. PubMed ID: 11704803
[TBL] [Abstract][Full Text] [Related]
3. Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4.
Urcelay E; Santiago JL; de la Calle H; Martínez A; Méndez J; Ibarra JM; Maluenda C; Fernández-Arquero M; de la Concha EG
BMC Genomics; 2005 Apr; 6():56. PubMed ID: 15842729
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland.
Haegert DG; Swift FV; Benedikz J
Neurology; 1996 Apr; 46(4):1107-11. PubMed ID: 8780100
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of tumor necrosis factor microsatellite alleles in genetic susceptibility to multiple sclerosis.
Sandberg-Wollheim M; Ciusani E; Salmaggi A; Pociot F
Mult Scler; 1995 Nov; 1(3):181-5. PubMed ID: 9345451
[TBL] [Abstract][Full Text] [Related]
6. Extended haplotype analysis reveals an association of TNF polymorphisms with susceptibility to systemic lupus erythematosus beyond HLA-DR3.
Schotte H; Willeke P; Tidow N; Domschke W; Assmann G; Gaubitz M; Schlüter B
Scand J Rheumatol; 2005; 34(2):114-21. PubMed ID: 16095006
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-associated susceptibility to type 1 diabetes is caused by linkage disequilibrium with HLA-DR3 haplotypes.
Kumar N; Kaur G; Tandon N; Mehra N
Hum Immunol; 2012 May; 73(5):566-73. PubMed ID: 22366579
[TBL] [Abstract][Full Text] [Related]
8. Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE.
Graham RR; Ortmann W; Rodine P; Espe K; Langefeld C; Lange E; Williams A; Beck S; Kyogoku C; Moser K; Gaffney P; Gregersen PK; Criswell LA; Harley JB; Behrens TW
Eur J Hum Genet; 2007 Aug; 15(8):823-30. PubMed ID: 17406641
[TBL] [Abstract][Full Text] [Related]
9. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course.
Barcellos LF; Oksenberg JR; Begovich AB; Martin ER; Schmidt S; Vittinghoff E; Goodin DS; Pelletier D; Lincoln RR; Bucher P; Swerdlin A; Pericak-Vance MA; Haines JL; Hauser SL;
Am J Hum Genet; 2003 Mar; 72(3):710-6. PubMed ID: 12557126
[TBL] [Abstract][Full Text] [Related]
10. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
[TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis associated amino acids of polymorphic regions relevant for the HLA antigen binding are confined to HLA-DR2.
Zipp F; Windemuth C; Pankow H; Dichgans J; Wienker T; Martin R; Müller C
Hum Immunol; 2000 Oct; 61(10):1021-30. PubMed ID: 11082515
[TBL] [Abstract][Full Text] [Related]
12. Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes.
Wiencke K; Karlsen TH; Boberg KM; Thorsby E; Schrumpf E; Lie BA; Spurkland A
Tissue Antigens; 2007 Feb; 69(2):161-9. PubMed ID: 17257319
[TBL] [Abstract][Full Text] [Related]
13. TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ.
Aminkeng F; Van Autreve JE; Koeleman BP; Quartier E; Van Schravendijk C; Gorus FK; Van der Auwera BJ;
Hum Immunol; 2007 Aug; 68(8):690-7. PubMed ID: 17678725
[TBL] [Abstract][Full Text] [Related]
14. Tumour necrosis factor microsatellites show association with multiple sclerosis.
Kirk CW; Droogan AG; Hawkins SA; McMillan SA; Nevin NC; Graham CA
J Neurol Sci; 1997 Mar; 147(1):21-5. PubMed ID: 9094056
[TBL] [Abstract][Full Text] [Related]
15. TNFA promoter polymorphisms and narcolepsy.
Wieczorek S; Gencik M; Rujescu D; Tonn P; Giegling I; Epplen JT; Dahmen N
Tissue Antigens; 2003 Jun; 61(6):437-42. PubMed ID: 12823767
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of HLA microsatellite marker in Tunisian pemphigus foliaceus.
Abida O; Mahfoudh N; Kammoun A; Gaddour L; Hakim F; Toumi A; Masmoudi A; Ben Ayed M; Turki H; Masmoudi H; Makni H
Hum Immunol; 2013 Jan; 74(1):104-9. PubMed ID: 23073295
[TBL] [Abstract][Full Text] [Related]
17. Absence of the tag polymorphism for the risk haplotype HLA-DR2 for multiple sclerosis in Wixárika subjects from Mexico.
González-Enríquez GV; Torres-Mendoza BM; Márquez-Pedroza J; Macías-Islas MA; Ortiz GG; Cruz-Ramos JA
Immunogenetics; 2018 Aug; 70(8):547-551. PubMed ID: 29397401
[TBL] [Abstract][Full Text] [Related]
18. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus.
Rood MJ; van Krugten MV; Zanelli E; van der Linden MW; Keijsers V; Schreuder GM; Verduyn W; Westendorp RG; de Vries RR; Breedveld FC; Verweij CL; Huizinga TW
Arthritis Rheum; 2000 Jan; 43(1):129-34. PubMed ID: 10643708
[TBL] [Abstract][Full Text] [Related]
19. The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-beta.
Villoslada P; Barcellos LF; Rio J; Begovich AB; Tintore M; Sastre-Garriga J; Baranzini SE; Casquero P; Hauser SL; Montalban X; Oksenberg JR
J Neuroimmunol; 2002 Sep; 130(1-2):194-201. PubMed ID: 12225902
[TBL] [Abstract][Full Text] [Related]
20. Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype.
Sospedra M; Muraro PA; Stefanová I; Zhao Y; Chung K; Li Y; Giulianotti M; Simon R; Mariuzza R; Pinilla C; Martin R
J Immunol; 2006 Feb; 176(3):1951-61. PubMed ID: 16424227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
